Northern Trust Corp Imara Inc. Transaction History

Northern Trust Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$3.73 - $5.2 $42,458 - $59,191	11,383 Added 74.33%	26,697 $109,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $7.83 $62,481 - $119,908	15,314 New	15,314 $62,000
Q2 2021 Aug 13, 2021	SELL	$6.78 - $9.04 $527,870 - $703,827	-77,857 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$8.18 - $23.98 $35,910 - $105,272	-4,390 Reduced 5.34%	77,857 $657,000
Q4 2020 Feb 11, 2021	BUY	$15.81 - $29.0 $334,666 - $613,872	21,168 Added 34.66%	82,247 $1.81 Million
Q3 2020 Nov 16, 2020	SELL	$18.75 - $28.58 $58,987 - $89,912	-3,146 Reduced 4.9%	61,079 $1.24 Million
Q2 2020 Aug 14, 2020	BUY	$15.6 - $54.87 $899,090 - $3.16 Million	57,634 Added 874.43%	64,225 $1.77 Million
Q1 2020 May 14, 2020	BUY	$15.0 - $16.6 $98,865 - $109,410	6,591 New	6,591 $106,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.